DocWire News Editors

DocwireNews

This study sought to evaluate the relationship between the progression of type 2 diabetes and detailed fasting glucose level with the risk of atrial fibrillation (AF). The analysis included a total of more than 6.19 million subjects who were not diagnosed with atrial fibrillation who underwent health check-up in 2009 from the Korean National Health Insurance Service database. The authors compared AF risk among subjects with normal fasting glucose (NFD), those with impaired fasting glucose (IFD), and those with diabetes &lt;5 years (early DM), and those with diabetes of five years or more (late DM). Participants were risk-stratified by fasting glucose level per 10 mg/dL. The risk of AF increased significantly across the time course of type 2 diabetes, according to the results, particularly in participants in the IFG group. &ldquo;the risk of AF increased with the time course of type 2 diabetes,&rdquo; the researchers said. &ldquo;However, low blood glucose in antidiabetic medication user was associated with an increased risk of AF.&rdquo;<a href="https://www.ajconline.org/article/S0002-9149(19)31047-1/fulltext">Yang S, et al. Am J Cardiol. 2019;doi:10.1016/j.amjcard.2019.09.009</a>

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Atrial Fibrillation Risk Across the Time Course of Type 2 Diabetes

Atrial Fibrillation

This study sought to evaluate the relationship between the progression of type 2 diabetes and detailed fasting glucose level with the risk of atrial fibrillation (AF). The ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe